HB-adMSCs for the Treatment of Crohn's Disease

NCT07077746 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn Disease (CD)

Interventions

DRUG: HB-adMSCs - Hope Biosciences Adipose Derived Mesenchymal Stem Cells
DRUG: 0.9% sodium chloride

Sponsor

Hope Biosciences Research Foundation